EJCTS Click here to locate an Ethicon representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the activity for this article:
Reconstructive surgery in active mitr...
Right arrow Erratum (v32,p557)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Alain Poncelet
Philippe Noirhomme
Gebrine El Khoury
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Kerchove, L.
Right arrow Articles by El Khoury, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Kerchove, L.
Right arrow Articles by El Khoury, G.
Related Collections
Right arrow Valve disease

Eur J Cardiothorac Surg 2007;31:592-599. doi:10.1016/j.ejcts.2007.01.002
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved

Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability

Laurent de Kerchovea,*, Jean-Louis Vanoverscheldeb, Alain Ponceleta, David Glineura, Jean Rubaya, Francis Zechc, Philippe Noirhommea, Gebrine El Khourya

a Division of Cardiothoracic and Vascular Surgery, Université Catholique de Louvain, Brussels, Belgium
b Division of Cardiology, Université Catholique de Louvain, Brussels, Belgium
c Division of Internal Medicine, Université Catholique de Louvain, Brussels, Belgium

Received 16 September 2006; received in revised form 19 December 2006; accepted 4 January 2007.

* Corresponding author. Address: Division of Cardiothoracic and Vascular Surgery, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, Belgium. Tel.: +32 2 764 6111; fax: +32 2 764 8960. (Email: Laurent.DeKerchove{at}clin.ucl.ac.be; ldekerchove{at}hotmail.com).

Objective: To evaluate timing for surgery and management of complex valve lesions in patients with active mitral valve (MV) endocarditis. Results are based on 13 years of experience with MV repair in active endocarditis. Method: Between 1993 and 2005, 81 patients were operated for active MV endocarditis, of which 63 (or 78%) had MV repair. For all patients, the median time between diagnosis and surgery was 10 days. Diverse surgical techniques were applied to restore MV competence. In 59% of the patients, pericardial patches, tricuspid autograft or partial MV homografts were used as leaflet substitutes. In addition, prosthetic rings were employed in 44% of the patients. Results: The overall operative mortality was 17.5%. However, considering only patients in preoperative NYHA class I or II, the operative mortality could be reduced to 4.8%. NYHA class ≥3, elevated age (above 70 years) and history of valvular were the three independent risks factors for early mortality in our multivariate analysis. The average follow-up time was 60 ± 37 months. During this period, five late deaths occurred, two of which were cardiac-related. The overall 5- and 10-year survival rate was 73 ± 12% and 69 ± 13%, respectively. In hospital survivors, freedom from cardiac death after 5 and 10 years was 93 ± 8%. Three early and five late MV reoperations occurred in seven patients, of them four could have MV re-repair. Only one endocarditis recurrence occurred after 4 months in a chronic haeamodialysed patient. Freedom from MV reoperation was 89 ± 10% and 72 ± 24% at 5 and 10 years, respectively. Ten-year freedom from MV replacement and from endocarditis recurrence were 95 ± 5% and 98 ± 1%, respectively. Annular abscesses and calcified or rheumatic MV disease were two independent risk factors associated with reoperation in our multivariate analysis. During the follow-up period, all patients were in NYHA class I or II; 89% of patients had mitral regurgitation grade ≤I, only 11% had grade II on transthoracic echocardiography. Conclusion: Using diverse and advanced techniques of MV repair, a reparability rate of 80% can be reached among patients with active endocarditis. We demonstrate that a high level of safety and excellent durability of MV repair can be obtained even for complex repairs.

Key Words: Mitral valve repair • Active endocarditis • Native valve endocarditis




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
C. Acar
Early surgery in mitral valve endocarditis: it is sometimes too early
Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 947 - 947.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.